[Osteoporosis in patients with diabetes mellitus].
Yamauchi
Mika
M
Internal Medicine 1, Shimane University Faculty of Medicine.
D015502:Absorptiometry, Photon; D000818:Animals; D015415:Biomarkers / Q000032:analysis; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001842:Bone and Bones / Q000378:metabolism; D002762:Cholecalciferol / Q000627:therapeutic use; D003094:Collagen / Q000378:metabolism; D048909:Diabetes Complications; D004164:Diphosphonates / Q000627:therapeutic use; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D017127:Glycation End Products, Advanced / Q000378:metabolism; D006801:Humans; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology* / Q000378:metabolism
D015415:Biomarkers; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D017127:Glycation End Products, Advanced; D002762:Cholecalciferol; D007334:Insulin-Like Growth Factor I; D003094:Collagen